ARCHIVES

In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely

This article is from The Cancer Letter archive.

Vol. 19 No. 42 | October 29, 1993

Download PDF Visit The Full Archive

Related Articles

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007

No Cancer Letter For Next Two Weeks

August 30, 1991

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

NCI Advisory Group, Other Cancer Meeting

May 26, 1978